Bryson W. Katona, Ph.D. - Publications

Affiliations: 
2009 Washington University, Saint Louis, St. Louis, MO 
Area:
Biochemistry, Organic Chemistry, Pharmacology

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Katona BW, Hojnacki T, Glynn RA, Paulosky KE, Szigety KM, Cao Y, Zhang X, Feng Z, He X, Ma J, Hua X. Menin-mediated repression of glycolysis in combination with autophagy protects colon cancer against small molecule EGFR inhibitors. Molecular Cancer Therapeutics. PMID 32879052 DOI: 10.1158/1535-7163.Mct-20-0101  0.347
2020 Kumar S, Dudzik CM, Reed M, Long JM, Wangensteen KJ, Katona BW. Upper endoscopy surveillance in Lynch syndrome detects gastric and duodenal adenocarcinomas. Cancer Prevention Research (Philadelphia, Pa.). PMID 32859614 DOI: 10.1158/1940-6207.Capr-20-0269  0.392
2020 Ebrahimzadeh JE, Long JM, Wang L, Nathanson JT, Siddique SM, Rustgi AK, Goldberg DS, Katona BW. Associations of sociodemographic and clinical factors with gastrointestinal cancer risk assessment appointment completion. Journal of Genetic Counseling. PMID 32227561 DOI: 10.1002/Jgc4.1254  0.328
2020 Heckert JM, Kipnis ST, Kumar S, Botterbusch S, Alderson A, Bennett B, Creamer C, Eads JR, Soulen MC, Pryma DA, Mankoff DA, Metz DC, Katona BW. Abnormal Pretreatment Liver Function Tests Are Associated with Discontinuation of Peptide Receptor Radionuclide Therapy in a U.S.-Based Neuroendocrine Tumor Cohort. The Oncologist. PMID 32141667 DOI: 10.1634/Theoncologist.2019-0743  0.304
2020 Clark DF, Michalski ST, Tondon R, Nehoray B, Ebrahimzadeh J, Hughes SK, Soper ER, Domchek SM, Rustgi AK, Pineda-Alvarez D, Anderson MJ, Katona BW. Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 32051609 DOI: 10.1038/S41436-020-0753-1  0.339
2019 Katona BW, Clark DF, Domchek SM. CDH1 on multigene panel testing: Look before you leap. Journal of the National Cancer Institute. PMID 31841163 DOI: 10.1093/Jnci/Djz229  0.366
2019 Powers JM, Ebrahimzadeh JE, Katona BW. Genetic testing for hereditary gastrointestinal cancer syndromes: Interpreting results in today's practice. Current Treatment Options in Gastroenterology. PMID 31761969 DOI: 10.1007/S11938-019-00253-2  0.327
2019 Katona BW, Weiss JM. Chemoprevention of Colorectal Cancer. Gastroenterology. PMID 31563626 DOI: 10.1053/J.Gastro.2019.06.047  0.345
2019 Kumar S, Long JM, Ginsberg GG, Katona BW. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome. World Journal of Gastroenterology. 25: 2878-2886. PMID 31249446 DOI: 10.3748/Wjg.V25.I23.2878  0.374
2019 Kumar S, Katona BW, Long JM, Domchek S, Rustgi AK, Roses R, Ginsberg GG. Endoscopic Ultrasound Has Limited Utility in Diagnosis of Gastric Cancer in Carriers of CDH1 Mutations. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 31077828 DOI: 10.1016/J.Cgh.2019.04.064  0.37
2019 Katona BW, Glynn RA, Paulosky KE, Feng Z, Davis CI, Ma J, Berry CT, Szigety KM, Matkar S, Liu Y, Wang H, Wu Y, He X, Freedman BD, Brady DC, et al. Combined menin and EGFR inhibitors synergize to suppress colorectal cancer via EGFR-independent and calcium-mediated repression of SKP2 transcription. Cancer Research. PMID 30877106 DOI: 10.1158/0008-5472.Can-18-2133  0.323
2019 Katona BW, Stadler ZK, Robson ME, Domchek SM. RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis. Journal of the National Cancer Institute. PMID 30715414 DOI: 10.1093/Jnci/Djz012  0.322
2019 Mahmud N, Stashek K, Katona BW, Tondon R, Shroff SG, Roses R, Furth EE, Metz DC. The incidence of neoplasia in patients with autoimmune metaplastic atrophic gastritis: a renewed call for surveillance. Annals of Gastroenterology. 32: 67-72. PMID 30598594 DOI: 10.20524/Aog.2018.0325  0.348
2019 Wang L, Nathanson JT, Long J, Ebrahimzadeh J, Kumar S, Wangensteen KJ, Katona BW, Rustgi AK. Tu1673 – Single-Gene Vs. Multi-Gene Panel Testing in Management of Hereditary Gastrointestinal Cancer Syndromes Gastroenterology. 156: S-1086. DOI: 10.1016/S0016-5085(19)39677-5  0.301
2018 MacFarland SP, Zelley K, Long JM, McKenna D, Mamula P, Domchek SM, Nathanson KL, Brodeur GM, Rustgi AK, Katona BW, Maxwell KN. Earlier colorectal cancer screening may be necessary in patients with Li-Fraumeni Syndrome. Gastroenterology. PMID 30243621 DOI: 10.1053/J.Gastro.2018.09.036  0.336
2018 Muller C, Lee SM, Barge W, Siddique SM, Berera S, Wideroff G, Tondon R, Chang J, Peterson M, Stoll J, Katona BW, Sussman DA, Melson J, Kupfer SS. Low Referral Rate for Genetic Testing in Racially and Ethnically Diverse Patients Despite Universal Colorectal Cancer Screening. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 30130624 DOI: 10.1016/J.Cgh.2018.08.038  0.323
2018 McKenna DB, Van Den Akker J, Zhou AY, Ryan L, Leon A, O'Connor R, Shah PD, Rustgi AK, Katona BW. Identification of a novel GREM1 duplication in a patient with multiple colon polyps. Familial Cancer. PMID 29804199 DOI: 10.1007/S10689-018-0090-6  0.343
2018 Katona BW, Yurgelun MB, Garber JE, Offit K, Domchek SM, Robson ME, Stadler ZK. A counseling framework for moderate-penetrance colorectal cancer susceptibility genes. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 29493579 DOI: 10.1038/Gim.2018.12  0.345
2018 Rustgi N, Shroff SG, Katona BW. Two types of gastric cancer caused by the same underlying condition. Gastroenterology. PMID 29410354 DOI: 10.1053/J.Gastro.2017.11.290  0.334
2018 Macfarland S, Zelley K, Long JM, Mckenna D, Brodeur GM, Rustgi AK, Katona BW, Maxwell KN. Colorectal cancer risk in Li-Fraumeni syndrome: Is it time for earlier surveillance? Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E13503  0.35
2018 Singh A, Steinhagen E, Katona BW. Approach to upper gastrointestinal tract lesions in familial adenomatous polyposis Seminars in Colon and Rectal Surgery. 29: 102-107. DOI: 10.1053/J.Scrs.2018.06.003  0.367
2018 Mahmud N, Tomizawa Y, Stashek KM, Katona BW, Metz DC. 1028 - Endoscopic Resection of Duodenal Carcinoid Tumors: A Single Center Comparison Between Simple Polypectomy and Endoscopic Mucosal Resection Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)31060-6  0.306
2017 Katona BW, Roccaro GA, Soulen MC, Yang YX, Bennett BJ, Riff BP, Glynn RA, Wild D, Nicolas GP, Pryma DA, Teitelbaum UR, Metz DC. Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis. Pancreas. 46: 1121-1126. PMID 28902781 DOI: 10.1097/Mpa.0000000000000919  0.303
2017 Katona BW, Yang YX. Colorectal cancer risk associated with the CHEK2 1100delC variant. European Journal of Cancer (Oxford, England : 1990). 83: 103-105. PMID 28734145 DOI: 10.1016/J.Ejca.2017.05.045  0.347
2017 Katona BW, Rustgi AK. Gastric Cancer Genomics: Advances and Future Directions. Cellular and Molecular Gastroenterology and Hepatology. 3: 211-217. PMID 28275688 DOI: 10.1016/J.Jcmgh.2017.01.003  0.356
2015 Matkar S, Sharma P, Gao S, Gurung B, Katona BW, Liao J, Muhammad AB, Kong XC, Wang L, Jin G, Dang CV, Hua X. An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis. Cancer Cell. 28: 472-85. PMID 26461093 DOI: 10.1016/J.Ccell.2015.09.005  0.343
2015 Zhu J, Sammons MA, Donahue G, Dou Z, Vedadi M, Getlik M, Barsyte-Lovejoy D, Al-awar R, Katona BW, Shilatifard A, Huang J, Hua X, Arrowsmith CH, Berger SL. Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. Nature. 525: 206-11. PMID 26331536 DOI: 10.1038/Nature15251  0.323
2014 Katona BW, Liu Y, Ma A, Jin J, Hua X. EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells. Cancer Biology & Therapy. 15: 1677-87. PMID 25535899 DOI: 10.4161/15384047.2014.972776  0.368
2014 Matkar S, Katona BW, Hua X. Harnessing the hidden antitumor power of the MLL-AF4 oncogene to fight leukemia. Cancer Cell. 25: 411-3. PMID 24735921 DOI: 10.1016/J.Ccr.2014.03.028  0.316
2014 Katona B, Sholomskas L, Hua X. Mo1648 Enhancing the Efficacy of EGFR Inhibitors in Colon Cancer Cells Through Targeted Disruption of Menin-MLL1 Gastroenterology. 146: S-626-S-627. DOI: 10.1016/S0016-5085(14)62265-4  0.333
2014 Katona B, Liu Y, Ma A, Jin J, Hua X. Mo1647 Inhibition of EZH2/EZH1 by UNC1999 Enhances the Potency of the EGFR Inhibitor Gefitinib in Colon Cancer Cells Gastroenterology. 146: S-626. DOI: 10.1016/S0016-5085(14)62264-2  0.336
2009 Katona BW, Anant S, Covey DF, Stenson WF. Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines. The Journal of Biological Chemistry. 284: 3354-64. PMID 19054763 DOI: 10.1074/Jbc.M805804200  0.468
2008 Katona BW, Krishnan K, Cai ZY, Manion BD, Benz A, Taylor A, Evers AS, Zorumski CF, Mennerick S, Covey DF. Neurosteroid analogues. 12. Potent enhancement of GABA-mediated chloride currents at GABAA receptors by ent-androgens. European Journal of Medicinal Chemistry. 43: 107-13. PMID 17434649 DOI: 10.1016/J.Ejmech.2007.02.017  0.457
2007 Katona BW, Cummins CL, Ferguson AD, Li T, Schmidt DR, Mangelsdorf DJ, Covey DF. Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids. Journal of Medicinal Chemistry. 50: 6048-58. PMID 17963371 DOI: 10.1021/Jm0707931  0.466
2007 Katona BW, Rath NP, Anant S, Stenson WF, Covey DF. Enantiomeric deoxycholic acid: total synthesis, characterization, and preliminary toxicity toward colon cancer cell lines. The Journal of Organic Chemistry. 72: 9298-307. PMID 17958446 DOI: 10.1021/Jo701559Q  0.51
2007 Li P, Bracamontes J, Katona BW, Covey DF, Steinbach JH, Akk G. Natural and enantiomeric etiocholanolone interact with distinct sites on the rat alpha1beta2gamma2L GABAA receptor. Molecular Pharmacology. 71: 1582-90. PMID 17341652 DOI: 10.1124/Mol.106.033407  0.452
Show low-probability matches.